Valuation: Becton, Dickinson and Company

Market Cap 4.17TCr 3.65TCr 3.37TCr 3.15TCr 5.92TCr 3,94700Cr 6.03TCr 40TCr 16TCr 1,94400Cr 16TCr 15TCr 6,78000Cr P/E 2026 *
37.7x
P/E 2027 * 29.1x
Enterprise Value 5.77TCr 5.05TCr 4.66TCr 4.35TCr 8.18TCr 5,45700Cr 8.33TCr 56TCr 22TCr 2,68800Cr 22TCr 21TCr 9,37400Cr EV / Sales 2026 *
3x
EV / Sales 2027 * 2.83x
Free-Float
74.04%
Yield 2026 *
2.54%
Yield 2027 * 2.59%
1 day-2.49%
1 week+7.55%
Current month+2.86%
1 month+2.86%
3 months-2.06%
6 months-22.46%
Current year-22.02%
1 week 144.61
Extreme 144.61
156.89
1 month 140.11
Extreme 140.11
156.89
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
26/06Sell

Executive/Senior Manager

-75 0.0000%
24/06Sell

Executive/Senior Manager

-1,100 0.0004%
22/06Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
-2.49%+7.55%-11.43%-41.91% 4.28TCr
-2.12%+3.31%-32.48%-15.72% 16TCr
-3.34%-1.31%-9.06%-9.84% 10TCr
+0.47%+4.31%-5.49%+48.53% 5.48TCr
+0.56%-3.80%+53.05%+53.64% 5.33TCr
-0.43%+13.63% - - 3.35TCr
-3.76%-2.49%-21.99%-47.36% 2.7TCr
+1.22%+8.88%+64.02%-4.87% 2.51TCr
-1.25%+5.07%-11.82%-4.72% 2.08TCr
-0.58%-0.47%-17.49%-3.52% 2.05TCr
Average -1.07%+4.78%+0.81%-2.86% 5.43TCr
Weighted average by Cap. -1.40%+4.48%-7.34%-2.75%

Financials

2026 *2027 *
Net sales 1.92TCr 1.68TCr 1.55TCr 1.45TCr 2.73TCr 1,81800Cr 2.78TCr 19TCr 7.23TCr 90TCr 7.22TCr 7.05TCr 3,12300Cr 1.97TCr 1.73TCr 1.59TCr 1.49TCr 2.8TCr 1,86600Cr 2.85TCr 19TCr 7.42TCr 92TCr 7.41TCr 7.24TCr 3,20500Cr
Net income 112.46Cr 98Cr 91Cr 85Cr 159.64Cr 11TCr 162.58Cr 1.09TCr 423.13Cr 5.24TCr 422.53Cr 413.03Cr 18TCr 144.92Cr 126.91Cr 117.12Cr 109.32Cr 205.72Cr 14TCr 209.5Cr 1.4TCr 545.25Cr 6.76TCr 544.47Cr 532.24Cr 24TCr
Net Debt 1.6TCr 1.4TCr 1.29TCr 1.2TCr 2.26TCr 1,51000Cr 2.31TCr 15TCr 6TCr 74TCr 5.99TCr 5.86TCr 2,59400Cr 1.41TCr 1.23TCr 1.14TCr 1.06TCr 2TCr 1,33200Cr 2.03TCr 14TCr 5.29TCr 66TCr 5.29TCr 5.17TCr 2,28800Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
30/26/30 $151.33 -2.49% 20,53,596
29/26/29 $155.19 -0.47% 23,96,596
26/26/26 $155.92 +3.00% 1,21,80,748
25/26/25 $151.38 +2.44% 25,48,949
24/26/24 $147.77 +2.68% 23,00,230
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
151.33USD
Average target price
177.75USD
Spread / Average Target
+17.46%

Quarterly revenue - Rate of surprise